JANUX THERAPEUTICS

Trade JANX
JANX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-11
2025-06-13
CAPPS VICKIE
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
CAPPS VICKIE
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
DOBMEIER ERIC
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
DOBMEIER ERIC
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
BARRETT RONALD
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
GUJRATHI SHEILA
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
GUJRATHI SHEILA
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
HERNDAY NATASHA
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
HERNDAY NATASHA
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
KUNG WINSTON
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
KUNG WINSTON
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
MCNULTY ALANA
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
MCNULTY ALANA
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Stock Option (Right to Buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
SIMSON JAKE
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
BARRETT RONALD
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
SIMSON JAKE
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
BARRETT RONALD
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
BARRETT RONALD
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
CAPPS VICKIE
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
CAPPS VICKIE
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
DOBMEIER ERIC
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
DOBMEIER ERIC
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
GUJRATHI SHEILA
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
GUJRATHI SHEILA
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
HERNDAY NATASHA
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
HERNDAY NATASHA
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
KUNG WINSTON
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
KUNG WINSTON
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
MCNULTY ALANA
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
MCNULTY ALANA
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Stock Option (Right to Buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-11
2025-06-13
SIMSON JAKE
A - Grant
Stock Option (right to buy)
11,667
$0.00
1
$1.49B
2025-06-11
2025-06-13
SIMSON JAKE
A - Grant
Common Stock
3,750
$0.00
1
$1.49B
2025-06-02
2025-06-04
DOYLE JANEEN NOEL
Chief Corp. & Bus. Dev. Ofcr
A - Grant
Stock option (right to buy)
154K
$0.00
1
$1.49B
2025-06-02
2025-06-04
DOYLE JANEEN NOEL
Chief Corp. & Bus. Dev. Ofcr
A - Grant
Common Stock
44,000
$0.00
1
$1.49B
2025-05-01
2025-05-02
MEYER ANDREW HOLLMAN
Chief Business Officer
S - Sale
Common Stock
-3,333
$32.00
-107K
2
$1.49B
2025-05-01
2025-05-02
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-3,333
$0.00
1
$1.49B
2025-05-01
2025-05-02
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Common Stock
3,333
$4.00
13,332
1
$1.49B
2025-05-01
2025-05-01
ANDREW MEYER
S - Sale
-3,333
$33.00
-110K
1
$1.49B
2025-04-21
2025-04-23
MEYER ANDREW HOLLMAN
Chief Business Officer
S - Sale
Common Stock
-3,334
$30.00
-100K
1
$1.49B
2025-04-21
2025-04-23
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-3,334
$0.00
1
$1.49B
2025-04-21
2025-04-23
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Common Stock
3,334
$4.00
13,336
1
$1.49B
2025-04-21
2025-04-21
ANDREW MEYER
S - Sale
-3,334
$30.00
-100K
1
$1.49B
2025-03-07
2025-03-07
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
110K
$31.00
3.42M
1
$1.49B
2025-03-06
2025-03-07
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
372K
$31.00
12M
1
$1.49B
2025-03-05
2025-03-07
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
342K
$31.00
11M
2
$1.49B
2025-03-03
2025-03-05
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-3,334
$0.00
1
$1.49B
2025-03-03
2025-03-05
MEYER ANDREW HOLLMAN
Chief Business Officer
S - Sale
Common Stock
-3,334
$32.00
-107K
2
$1.49B
2025-03-03
2025-03-05
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Common Stock
3,334
$4.00
13,336
1
$1.49B
2025-03-03
2025-03-03
ANDREW MEYER
S - Sale
-3,334
$33.00
-110K
1
$1.49B
2025-02-03
2025-02-05
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-3,334
$0.00
1
$1.49B
2025-02-03
2025-02-05
MEYER ANDREW HOLLMAN
Chief Business Officer
S - Sale
Common Stock
-3,334
$42.00
-140K
3
$1.49B
2025-02-03
2025-02-05
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Common Stock
3,334
$4.00
13,336
1
$1.49B
2025-02-03
2025-02-03
ANDREW MEYER
S - Sale
-3,334
$43.00
-143K
1
$1.49B
2025-01-07
2025-01-08
CAMPBELL DAVID ALAN
President and CEO
S - Sale
Common Stock
-5,000
$60.00
-300K
1
$1.49B
2025-01-02
2025-01-03
MCIVER ZACHARIAH
Chief Medical Officer
A - Grant
Common Stock
26,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
CAMPBELL DAVID ALAN
President and CEO
A - Grant
Stock option (right to buy)
284K
$0.00
1
$1.49B
2025-01-02
2025-01-03
CAMPBELL DAVID ALAN
President and CEO
A - Grant
Common Stock
81,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
CAMPBELL DAVID ALAN
President and CEO
A - Grant
Stock option (right to buy)
284K
$0.00
1
$1.49B
2025-01-02
2025-01-03
CAMPBELL DAVID ALAN
President and CEO
A - Grant
Common Stock
81,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
DIRAIMONDO THOMAS
Chief Scientific Officer
A - Grant
Stock option (right to buy)
84,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
DIRAIMONDO THOMAS
Chief Scientific Officer
A - Grant
Common Stock
24,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MEYER ANDREW HOLLMAN
Chief Business Officer
A - Grant
Common Stock
18,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
ROBINSON BYRON
Chief Strategy Officer
A - Grant
Stock option (right to buy)
98,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
ROBINSON BYRON
Chief Strategy Officer
A - Grant
Common Stock
28,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
WINTER CHARLES
Chief Technical Officer
A - Grant
Stock option (right to buy)
80,500
$0.00
1
$1.49B
2025-01-02
2025-01-03
WINTER CHARLES
Chief Technical Officer
A - Grant
Common Stock
23,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
DIRAIMONDO THOMAS
Chief Scientific Officer
A - Grant
Stock option (right to buy)
84,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
DIRAIMONDO THOMAS
Chief Scientific Officer
A - Grant
Common Stock
24,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
DOBEK MARIA
Vice President, Accounting
A - Grant
Stock option (right to buy)
31,500
$0.00
1
$1.49B
2025-01-02
2025-01-03
DOBEK MARIA
Vice President, Accounting
A - Grant
Common Stock
14,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MCIVER ZACHARIAH
Chief Medical Officer
A - Grant
Stock option (right to buy)
91,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MEYER ANDREW HOLLMAN
Chief Business Officer
A - Grant
Stock option (right to buy)
63,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
DOBEK MARIA
Vice President, Accounting
A - Grant
Stock option (right to buy)
31,500
$0.00
1
$1.49B
2025-01-02
2025-01-03
DOBEK MARIA
Vice President, Accounting
A - Grant
Common Stock
14,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MCIVER ZACHARIAH
Chief Medical Officer
A - Grant
Stock option (right to buy)
91,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MCIVER ZACHARIAH
Chief Medical Officer
A - Grant
Common Stock
26,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MEYER ANDREW HOLLMAN
Chief Business Officer
A - Grant
Stock option (right to buy)
63,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MEYER ANDREW HOLLMAN
Chief Business Officer
A - Grant
Common Stock
18,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MEYER ANDREW HOLLMAN
Chief Business Officer
S - Sale
Common Stock
-13,334
$55.00
-733K
5
$1.49B
2025-01-02
2025-01-03
ROBINSON BYRON
Chief Strategy Officer
A - Grant
Stock option (right to buy)
98,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
ROBINSON BYRON
Chief Strategy Officer
A - Grant
Common Stock
28,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
WINTER CHARLES
Chief Technical Officer
A - Grant
Stock option (right to buy)
80,500
$0.00
1
$1.49B
2025-01-02
2025-01-03
WINTER CHARLES
Chief Technical Officer
A - Grant
Common Stock
23,000
$0.00
1
$1.49B
2025-01-02
2025-01-03
MEYER ANDREW HOLLMAN
Chief Business Officer
S - Sale
Common Stock
-13,334
$55.00
-733K
5
$1.49B
2025-01-02
2025-01-02
ANDREW MEYER
S - Sale
-13,334
$54.00
-720K
1
$1.49B
2024-12-24
2024-12-27
CAMPBELL DAVID ALAN
President and CEO
S - Sale
Common Stock
-25,000
$56.00
-1.40M
1
$1.49B
2024-12-26
2024-12-26
CAMPBELL DAVID ALAN
President and CEO
S - Sale
-25,000
$56.00
-1.40M
1
$1.49B
2024-12-19
2024-12-20
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-9,881
$0.00
2
$1.49B
2024-12-19
2024-12-20
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Common Stock
9,881
$20.00
198K
2
$1.49B
2024-12-19
2024-12-20
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-9,881
$0.00
2
$1.49B
2024-12-19
2024-12-20
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Common Stock
9,881
$20.00
198K
2
$1.49B
2024-12-03
2024-12-03
CAMPBELL DAVID ALAN
President and CEO
S - Sale
Common Stock
-15,000
$67.00
-1.00M
1
$1.49B
2024-11-25
2024-11-27
CAMPBELL DAVID ALAN
President and CEO
S - Sale
Common Stock
-25,000
$52.00
-1.30M
2
$1.49B
2024-11-05
2024-11-07
CAPPS VICKIE
J - Other
Common Stock
2,305
$0.00
1
$1.49B
2024-11-05
2024-11-07
GUJRATHI SHEILA
J - Other
Common Stock
4,611
$0.00
1
$1.49B
2024-11-01
2024-11-01
LICHTER JAY
S - Sale
-1,139
$53.00
-60,367
1
$1.49B
2024-11-01
2024-11-01
AVALON BIOVENTURES I, LP
S - Sale
-10,934
$54.00
-590K
1
$1.49B
2024-11-01
2024-11-01
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-57,627
$54.00
-3.11M
1
$1.49B
2024-11-01
2024-11-01
AVALON VENTURES XI, L.P.
S - Sale
-56,440
$54.00
-3.05M
1
$1.49B
2024-11-01
2024-11-01
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-8,201
$53.00
-435K
2
$1.49B
2024-10-28
2024-10-30
CAMPBELL DAVID ALAN
President and CEO
S - Sale
Common Stock
-25,000
$54.00
-1.35M
2
$1.49B
2024-10-28
2024-10-28
LICHTER JAY
S - Sale
-3,419
$54.00
-185K
1
$1.49B
2024-10-28
2024-10-28
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-24,183
$53.00
-1.28M
2
$1.49B
2024-10-25
2024-10-25
AVALON VENTURES XI, L.P.
S - Sale
-169K
$53.00
-8.97M
1
$1.49B
2024-10-25
2024-10-25
AVALON BIOVENTURES I, LP
S - Sale
-32,800
$53.00
-1.74M
1
$1.49B
2024-10-25
2024-10-25
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-173K
$53.00
-9.16M
1
$1.49B
2024-10-24
2024-10-25
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-21,760
$53.00
-1.15M
1
$1.49B
2024-10-24
2024-10-24
LICHTER JAY
S - Sale
-4,921
$53.00
-261K
1
$1.49B
2024-10-24
2024-10-24
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-218K
$5.00
-1.09M
1
$1.49B
2024-09-13
2024-10-24
LICHTER JAY
M - Exercise
Stock Option (right to buy)
-3,815
$0.00
4
$1.49B
2024-09-13
2024-10-24
LICHTER JAY
M - Exercise
Common Stock
3,815
$17.00
64,855
4
$1.49B
2024-09-13
2024-10-24
LICHTER JAY
S - Sale
Common Stock
-3,815
$47.00
-179K
1
$1.49B
2024-10-23
2024-10-23
AVALON VENTURES XI, L.P.
S - Sale
-244K
$51.00
-12M
1
$1.49B
2024-10-23
2024-10-23
AVALON BIOVENTURES I, LP
S - Sale
-47,203
$51.00
-2.41M
1
$1.49B
2024-10-23
2024-10-23
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-249K
$51.00
-13M
1
$1.49B
2024-10-23
2024-10-23
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-13,039
$51.00
-665K
1
$1.49B
2024-10-18
2024-10-22
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
1.20M
$45.00
54M
1
$1.49B
2024-10-21
2024-10-21
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-17,093
$50.00
-855K
2
$1.49B
2024-10-21
2024-10-21
LICHTER JAY
S - Sale
-2,434
$49.00
-119K
1
$1.49B
2024-10-18
2024-10-18
AVALON VENTURES XI, L.P.
S - Sale
-118K
$50.00
-5.91M
1
$1.49B
2024-10-18
2024-10-18
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-1.46M
$46.00
-67M
9
$1.49B
2024-10-18
2024-10-18
AVALON BIOVENTURES I, LP
S - Sale
-22,895
$50.00
-1.14M
1
$1.49B
2024-10-18
2024-10-18
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-121K
$50.00
-6.03M
1
$1.49B
2024-10-17
2024-10-18
AVALON VENTURES XI, L.P.
M - Exercise
Stock Option (right to buy)
-1,769
$0.00
4
$1.49B
2024-10-17
2024-10-18
AVALON VENTURES XI, L.P.
M - Exercise
Common Stock
1,769
$18.00
31,842
4
$1.49B
2024-10-17
2024-10-18
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-1,843
$50.00
-92,150
1
$1.49B
2024-10-16
2024-10-18
AVALON VENTURES XI, L.P.
M - Exercise
Common Stock
10,515
$18.00
189K
4
$1.49B
2024-10-16
2024-10-18
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-210K
$50.00
-10M
7
$1.49B
2024-10-16
2024-10-18
AVALON VENTURES XI, L.P.
M - Exercise
Stock Option (right to buy)
-10,515
$0.00
4
$1.49B
2024-10-17
2024-10-17
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-12,942
$50.00
-647K
2
$1.49B
2024-10-17
2024-10-17
LICHTER JAY
S - Sale
-1,842
$50.00
-92,100
1
$1.49B
2024-10-16
2024-10-16
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-91,539
$50.00
-4.58M
1
$1.49B
2024-10-16
2024-10-16
AVALON VENTURES XI, L.P.
S - Sale
-89,653
$50.00
-4.48M
1
$1.49B
2024-10-16
2024-10-16
AVALON BIOVENTURES I, LP
S - Sale
-17,367
$50.00
-868K
1
$1.49B
2024-10-16
2024-10-16
LICHTER JAY
S - Sale
-10,957
$51.00
-559K
1
$1.49B
2024-10-16
2024-10-16
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-77,455
$51.00
-3.95M
2
$1.49B
2024-09-30
2024-09-30
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-958
$46.00
-44,068
1
$1.49B
2024-09-30
2024-09-30
LICHTER JAY
S - Sale
-958
$46.00
-44,068
1
$1.49B
2024-09-30
2024-09-30
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-7,030
$46.00
-323K
2
$1.49B
2024-09-30
2024-09-30
AVALON VENTURES XI, L.P.
M - Exercise
Stock Option (right to buy)
-919
$0.00
4
$1.49B
2024-09-30
2024-09-30
AVALON VENTURES XI, L.P.
M - Exercise
Common Stock
919
$18.00
16,542
4
$1.49B
2024-09-27
2024-09-30
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-107K
$46.00
-4.91M
7
$1.49B
2024-09-27
2024-09-30
AVALON VENTURES XI, L.P.
M - Exercise
Stock Option (right to buy)
-1,752
$0.00
4
$1.49B
2024-09-27
2024-09-30
AVALON VENTURES XI, L.P.
M - Exercise
Common Stock
1,752
$18.00
31,536
4
$1.49B
2024-09-26
2024-09-30
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-200K
$47.00
-9.40M
6
$1.49B
2024-09-27
2024-09-27
CAMPBELL DAVID ALAN
President and CEO
S - Sale
-90,000
$48.00
-4.32M
1
$1.49B
2024-09-27
2024-09-27
MEYER ANDREW HOLLMAN
Chief Business Officer
S - Sale
Common Stock
-50,000
$46.00
-2.30M
1
$1.49B
2024-09-27
2024-09-27
ANDY MEYER
S - Sale
-50,000
$46.00
-2.30M
1
$1.49B
2024-09-27
2024-09-27
AVALON BIOVENTURES I, LP
S - Sale
-9,187
$46.00
-423K
1
$1.49B
2024-09-27
2024-09-27
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-48,403
$46.00
-2.23M
1
$1.49B
2024-09-27
2024-09-27
AVALON VENTURES XI, L.P.
S - Sale
-47,405
$46.00
-2.18M
1
$1.49B
2024-09-27
2024-09-27
CAMPBELL DAVID ALAN
President and CEO
S - Sale
Common Stock
-25,000
$46.00
-1.15M
3
$1.49B
2024-09-27
2024-09-27
DIRAIMONDO THOMAS
Chief Scientific Officer
S - Sale
Common Stock
-5,000
$46.00
-230K
2
$1.49B
2024-09-27
2024-09-27
LICHTER JAY
S - Sale
-1,826
$46.00
-83,996
1
$1.49B
2024-09-27
2024-09-27
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-12,644
$46.00
-582K
2
$1.49B
2024-09-27
2024-09-27
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-50,000
$0.00
1
$1.49B
2024-09-27
2024-09-27
MEYER ANDREW HOLLMAN
Chief Business Officer
M - Exercise
Common Stock
50,000
$4.00
200K
1
$1.49B
2024-09-26
2024-09-26
AVALON BIOVENTURES I, LP
S - Sale
-17,500
$47.00
-823K
1
$1.49B
2024-09-26
2024-09-26
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-92,200
$47.00
-4.33M
1
$1.49B
2024-09-26
2024-09-26
AVALON VENTURES XI, L.P.
S - Sale
-90,300
$47.00
-4.24M
1
$1.49B
2024-09-12
2024-09-12
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-161K
$47.00
-7.58M
1
$1.49B
2024-09-12
2024-09-12
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-15,223
$47.00
-715K
1
$1.49B
2024-09-12
2024-09-12
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-350K
$47.00
-16M
3
$1.49B
2024-09-12
2024-09-12
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-8,819
$48.00
-423K
1
$1.49B
2024-09-12
2024-09-12
AVALON VENTURES XI, L.P.
S - Sale
-158K
$47.00
-7.43M
1
$1.49B
2024-09-12
2024-09-12
AVALON BIOVENTURES I, LP
S - Sale
-30,613
$47.00
-1.44M
1
$1.49B
2024-09-10
2024-09-12
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-101K
$47.00
-4.75M
6
$1.49B
2024-09-10
2024-09-11
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-2,055
$47.00
-96,585
1
$1.49B
2024-09-10
2024-09-10
AVALON BIOVENTURES I, LP
S - Sale
-8,842
$46.00
-407K
1
$1.49B
2024-09-10
2024-09-10
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-46,604
$46.00
-2.14M
1
$1.49B
2024-09-10
2024-09-10
AVALON VENTURES XI, L.P.
S - Sale
-45,645
$46.00
-2.10M
1
$1.49B
2024-09-10
2024-09-10
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-5,359
$46.00
-247K
2
$1.49B
2024-09-09
2024-09-10
AVALON VENTURES XI, L.P.
M - Exercise
Stock Option (right to buy)
-2,099
$0.00
4
$1.49B
2024-09-09
2024-09-10
AVALON VENTURES XI, L.P.
M - Exercise
Common Stock
2,099
$18.00
37,782
4
$1.49B
2024-09-09
2024-09-10
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-2,182
$42.00
-91,644
1
$1.49B
2024-09-06
2024-09-10
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-240K
$42.00
-10M
3
$1.49B
2024-09-09
2024-09-09
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-15,031
$42.00
-631K
2
$1.49B
2024-09-09
2024-09-09
LICHTER JAY
S - Sale
-2,182
$42.00
-91,644
1
$1.49B
2024-09-09
2024-09-09
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
-5,762
$42.00
-242K
1
$1.49B
2024-09-06
2024-09-06
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-111K
$41.00
-4.54M
1
$1.49B
2024-09-06
2024-09-06
AVALON BIOVENTURES I, LP
S - Sale
-20,991
$41.00
-861K
1
$1.49B
2024-09-06
2024-09-06
AVALON VENTURES XI, L.P.
S - Sale
-108K
$41.00
-4.44M
1
$1.49B
2024-07-19
2024-07-24
DOBMEIER ERIC
A - Grant
Stock Option (Right to Buy)
4,111
$0.00
1
$1.49B
2024-07-19
2024-07-24
DOBMEIER ERIC
A - Grant
Common Stock
1,231
$0.00
1
$1.49B
2024-07-19
2024-07-24
HERNDAY NATASHA
A - Grant
Stock Option (Right to Buy)
4,111
$0.00
1
$1.49B
2024-07-19
2024-07-24
HERNDAY NATASHA
A - Grant
Common Stock
1,231
$0.00
1
$1.49B
2024-07-19
2024-07-22
HERNDAY NATASHA
A - Grant
Stock Option (Right to Buy)
25,050
$0.00
2
$1.49B
2024-07-19
2024-07-22
DOBMEIER ERIC
A - Grant
Stock Option (Right to Buy)
25,050
$0.00
2
$1.49B
2024-07-19
2024-07-22
DOBMEIER ERIC
A - Grant
Common Stock
7,500
$0.00
2
$1.49B
2024-07-19
2024-07-22
HERNDAY NATASHA
A - Grant
Common Stock
7,500
$0.00
2
$1.49B
2024-06-26
2024-06-28
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Stock Option (Right to Buy)
8,350
$0.00
1
$1.49B
2024-06-26
2024-06-28
KUNG WINSTON
A - Grant
Stock Option (right to buy)
8,350
$0.00
1
$1.49B
2024-06-26
2024-06-28
KUNG WINSTON
A - Grant
Common Stock
2,500
$0.00
1
$1.49B
2024-06-26
2024-06-28
LICHTER JAY
A - Grant
Stock Option (right to buy)
8,350
$0.00
1
$1.49B
2024-06-26
2024-06-28
BARRETT RONALD
A - Grant
Stock Option (right to buy)
8,350
$0.00
1
$1.49B
2024-06-26
2024-06-28
BARRETT RONALD
A - Grant
Common Stock
2,500
$0.00
1
$1.49B
2024-06-26
2024-06-28
CAPPS VICKIE
A - Grant
Stock Option (right to buy)
8,350
$0.00
1
$1.49B
2024-06-26
2024-06-28
CAPPS VICKIE
A - Grant
Common Stock
2,500
$0.00
1
$1.49B
2024-06-26
2024-06-28
GUJRATHI SHEILA
A - Grant
Stock Option (right to buy)
8,350
$0.00
1
$1.49B
2024-06-26
2024-06-28
GUJRATHI SHEILA
A - Grant
Common Stock
2,500
$0.00
1
$1.49B
2024-06-26
2024-06-28
LICHTER JAY
A - Grant
Common Stock
2,500
$0.00
1
$1.49B
2024-06-26
2024-06-28
MCNULTY ALANA
A - Grant
Stock Option (right to buy)
8,350
$0.00
1
$1.49B
2024-06-26
2024-06-28
MCNULTY ALANA
A - Grant
Common Stock
2,500
$0.00
1
$1.49B
2024-06-26
2024-06-28
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Common Stock
2,500
$0.00
1
$1.49B
2024-06-26
2024-06-28
SIMSON JAKE
A - Grant
Stock Option (right to buy)
8,350
$0.00
1
$1.49B
2024-06-26
2024-06-28
SIMSON JAKE
A - Grant
Common Stock
2,500
$0.00
1
$1.49B
2024-06-03
2024-06-05
AVALON VENTURES XI, L.P.
S - Sale
Common Stock
-1.50M
$55.00
-83M
3
$1.49B
2024-06-03
2024-06-05
LICHTER JAY
S - Sale
Common Stock
-1.50M
$55.00
-83M
3
$1.49B
2024-06-03
2024-06-05
REARDON TIGHE
Acting Chief Financial Officer
S - Sale
Common Stock
-823K
$55.00
-45M
2
$1.49B
2024-06-03
2024-06-03
AVALON BIOVENTURES I, LP
S - Sale
-131K
$55.00
-7.22M
1
$1.49B
2024-06-03
2024-06-03
AVALON BIOVENTURES SPV I, L.P.
S - Sale
-692K
$55.00
-38M
1
$1.49B
2024-06-03
2024-06-03
AVALON VENTURES XI, L.P.
S - Sale
-677K
$55.00
-37M
1
$1.49B
2024-03-04
2024-03-06
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Pre-Funded Warrants (Right to Buy)
1.40M
$46.00
64M
1
$1.49B
2024-02-29
2024-03-04
AVALON VENTURES XI, L.P.
J - Other
Common Stock
44,544
$0.00
3
$1.49B
2024-02-29
2024-03-04
AVALON VENTURES XI, L.P.
J - Other
Common Stock
-1.02M
$0.00
6
$1.49B
2024-02-29
2024-03-04
CAPPS VICKIE
J - Other
Common Stock
1,493
$0.00
1
$1.49B
2024-02-29
2024-03-04
GUJRATHI SHEILA
J - Other
Common Stock
2,986
$0.00
1
$1.49B
2024-01-02
2024-01-03
CAMPBELL DAVID ALAN
President and CEO
A - Grant
Stock Option (right to buy)
357K
$0.00
1
$1.49B
2024-01-02
2024-01-03
DIRAIMONDO THOMAS
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
147K
$0.00
1
$1.49B
2024-01-02
2024-01-03
MEYER ANDREW HOLLMAN
Chief Business Officer
A - Grant
Stock Option (right to buy)
105K
$0.00
1
$1.49B
2024-01-02
2024-01-03
REARDON TIGHE
Acting Chief Financial Officer
A - Grant
Stock Option (right to buy)
157K
$0.00
1
$1.49B
2024-01-02
2024-01-03
ROBINSON BYRON
Chief Strategy Officer
A - Grant
Stock Option (right to buy)
152K
$0.00
1
$1.49B
2024-01-02
2024-01-03
WINTER CHARLES
Chief Technical Officer
A - Grant
Stock Option (right to buy)
111K
$0.00
1
$1.49B
2023-11-13
2023-11-15
LICHTER JAY
P - Purchase
Common Stock
850K
$6.00
5.10M
1
$1.49B
2023-11-13
2023-11-15
REARDON TIGHE
Acting Chief Financial Officer
P - Purchase
Common Stock
850K
$6.00
5.10M
1
$1.49B
2023-11-13
2023-11-13
AVALON VENTURES XI, L.P.
P - Purchase
Common Stock
850K
$6.00
5.10M
1
$1.49B
2023-09-07
2023-09-07
GODFREY WAYNE
Chief Medical Officer
S - Sale
-10,000
$11.00
-110K
1
$1.49B
2023-08-14
2023-08-14
GODFREY WAYNE
Chief Medical Officer
S - Sale
-234K
$12.00
-2.80M
1
$1.49B
2023-07-19
2023-07-21
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Pre-Funded Warrants (Right to Buy)
503K
$12.00
6.04M
1
$1.49B
2023-07-19
2023-07-21
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
495K
$12.00
5.94M
1
$1.49B
2023-06-14
2023-06-16
BARRETT RONALD
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2023-06-14
2023-06-16
CAPPS VICKIE
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2023-06-14
2023-06-16
GUJRATHI SHEILA
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2023-06-14
2023-06-16
KUNG WINSTON
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2023-06-14
2023-06-16
LICHTER JAY
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2023-06-14
2023-06-16
MCNULTY ALANA
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2023-06-14
2023-06-16
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Stock Option (Right to Buy)
12,500
$0.00
1
$1.49B
2023-06-14
2023-06-16
SIMSON JAKE
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2023-01-03
2023-01-05
CAMPBELL DAVID ALAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
310K
$0.00
1
$1.49B
2023-01-03
2023-01-05
GODFREY WAYNE
Chief Medical Officer
A - Grant
Stock Option (right to buy)
110K
$0.00
1
$1.49B
2023-01-03
2023-01-05
MEYER ANDREW HOLLMAN
Chief Business Officer
A - Grant
Stock Option (right to buy)
90,000
$0.00
1
$1.49B
2023-01-03
2023-01-05
REARDON TIGHE
Acting Chief Financial Officer
A - Grant
Stock Option (right to buy)
110K
$0.00
1
$1.49B
2023-01-03
2023-01-05
ROBINSON BYRON
Chief Strategy Officer
A - Grant
Stock Option (right to buy)
100K
$0.00
1
$1.49B
2023-01-03
2023-01-05
WINTER CHARLES
Chief Technical Officer
A - Grant
Stock Option (right to buy)
100K
$0.00
1
$1.49B
2022-09-21
2022-09-22
KUNG WINSTON
A - Grant
Stock Option (right to buy)
39,375
$0.00
2
$1.49B
2022-06-14
2022-06-16
BARRETT RONALD
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2022-06-14
2022-06-16
CAPPS VICKIE
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2022-06-14
2022-06-16
GUJRATHI SHEILA
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2022-06-14
2022-06-16
HELLER STEFAN
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2022-06-14
2022-06-16
LICHTER JAY
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2022-06-14
2022-06-16
MCNULTY ALANA
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2022-06-14
2022-06-16
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Stock Option (Right to Buy)
12,500
$0.00
1
$1.49B
2022-06-14
2022-06-16
SIMSON JAKE
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2022-06-14
2022-06-16
THOMPSON PETER
A - Grant
Stock Option (right to buy)
12,500
$0.00
1
$1.49B
2022-03-01
2022-03-03
ROBINSON BYRON
Chief Strategy Officer
A - Grant
Stock Option (right to buy)
230K
$0.00
1
$1.49B
2022-01-03
2022-01-05
CAMPBELL DAVID ALAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
354K
$0.00
1
$1.49B
2022-01-03
2022-01-05
GODFREY WAYNE
Chief Medical Officer
A - Grant
Stock Option (right to buy)
114K
$0.00
1
$1.49B
2022-01-03
2022-01-05
MEYER ANDREW HOLLMAN
Chief Business Officer
A - Grant
Stock Option (right to buy)
107K
$0.00
1
$1.49B
2022-01-03
2022-01-05
REARDON TIGHE
Acting Chief Financial Officer
A - Grant
Stock Option (right to buy)
117K
$0.00
1
$1.49B
2022-01-03
2022-01-05
SALEK-ARDAKANI SHAHRAM
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
114K
$0.00
1
$1.49B
2021-12-29
2021-12-30
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-40,400
$20.00
-808K
2
$1.49B
2021-12-29
2021-12-30
THOMPSON PETER
S - Sale
Common Stock
-40,400
$20.00
-808K
2
$1.49B
2021-12-21
2021-12-23
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-119K
$19.00
-2.27M
2
$1.49B
2021-12-21
2021-12-23
THOMPSON PETER
S - Sale
Common Stock
-119K
$19.00
-2.27M
2
$1.49B
2021-12-16
2021-12-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-393K
$19.00
-7.47M
2
$1.49B
2021-12-16
2021-12-17
THOMPSON PETER
S - Sale
Common Stock
-393K
$19.00
-7.47M
2
$1.49B
2021-09-07
2021-09-09
BARRETT RONALD
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$1.49B
2021-09-07
2021-09-09
MCNULTY ALANA
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$1.49B
2021-06-15
2021-06-16
REARDON TIGHE
Acting Chief Financial Officer
C - Conversion
Series A Convertible Preferred Stock
-2.11M
1
$1.49B
2021-06-15
2021-06-16
REARDON TIGHE
Acting Chief Financial Officer
C - Conversion
Series B Convertible Preferred Stock
-900K
1
$1.49B
2021-06-15
2021-06-16
REARDON TIGHE
Acting Chief Financial Officer
C - Conversion
Common Stock
3.85M
2
$1.49B
2021-06-15
2021-06-16
THOMPSON PETER
C - Conversion
Series A Convertible Preferred Stock
-1.05M
1
$1.49B
2021-06-15
2021-06-16
THOMPSON PETER
C - Conversion
Series B Convertible Preferred Stock
-772K
2
$1.49B
2021-06-15
2021-06-16
THOMPSON PETER
C - Conversion
Common Stock
2.34M
3
$1.49B
2021-06-15
2021-06-16
AVALON VENTURES XI, L.P.
P - Purchase
Common Stock
629K
$17.00
11M
1
$1.49B
2021-06-15
2021-06-16
BREGUA CORP
P - Purchase
Common Stock
58,823
$17.00
1000K
1
$1.49B
2021-06-15
2021-06-16
LICHTER JAY
P - Purchase
Common Stock
629K
$17.00
11M
1
$1.49B
2021-06-15
2021-06-16
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
706K
$17.00
12M
2
$1.49B
2021-06-15
2021-06-16
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
2.94M
$17.00
50M
2
$1.49B
2021-06-15
2021-06-16
REARDON TIGHE
Acting Chief Financial Officer
P - Purchase
Common Stock
629K
$17.00
11M
1
$1.49B
2021-06-15
2021-06-16
THOMPSON PETER
P - Purchase
Common Stock
706K
$17.00
12M
2
$1.49B
2021-06-15
2021-06-16
AVALON VENTURES XI, L.P.
C - Conversion
Series A Convertible Preferred Stock
-2.63M
2
$1.49B
2021-06-15
2021-06-16
AVALON VENTURES XI, L.P.
C - Conversion
Series B Convertible Preferred Stock
-900K
1
$1.49B
2021-06-15
2021-06-16
AVALON VENTURES XI, L.P.
C - Conversion
Series Seed 2 Convertible Preferred Stock
-1.86M
1
$1.49B
2021-06-15
2021-06-16
AVALON VENTURES XI, L.P.
C - Conversion
Series Seed Convertible Preferred Stock
-889K
1
$1.49B
2021-06-15
2021-06-16
AVALON VENTURES XI, L.P.
C - Conversion
Common Stock
8.05M
5
$1.49B
2021-06-15
2021-06-16
BREGUA CORP
C - Conversion
Series A Convertible Preferred Stock
-526K
1
$1.49B
2021-06-15
2021-06-16
BREGUA CORP
C - Conversion
Series B Convertible Preferred Stock
-193K
1
$1.49B
2021-06-15
2021-06-16
BREGUA CORP
C - Conversion
Series Seed 2 Convertible Preferred Stock
-1.27M
1
$1.49B
2021-06-15
2021-06-16
BREGUA CORP
C - Conversion
Series Seed Convertible Preferred Stock
-889K
1
$1.49B
2021-06-15
2021-06-16
BREGUA CORP
C - Conversion
Common Stock
3.69M
4
$1.49B
2021-06-15
2021-06-16
LICHTER JAY
C - Conversion
Series A Convertible Preferred Stock
-2.63M
2
$1.49B
2021-06-15
2021-06-16
LICHTER JAY
C - Conversion
Series B Convertible Preferred Stock
-900K
1
$1.49B
2021-06-15
2021-06-16
LICHTER JAY
C - Conversion
Series Seed 2 Convertible Preferred Stock
-1.86M
1
$1.49B
2021-06-15
2021-06-16
LICHTER JAY
C - Conversion
Series Seed Convertible Preferred Stock
-889K
1
$1.49B
2021-06-15
2021-06-16
LICHTER JAY
C - Conversion
Common Stock
8.05M
5
$1.49B
2021-06-15
2021-06-16
ORBIMED ADVISORS LLC
C - Conversion
Series A Convertible Preferred Stock
-1.05M
1
$1.49B
2021-06-15
2021-06-16
ORBIMED ADVISORS LLC
C - Conversion
Series B Convertible Preferred Stock
-772K
2
$1.49B
2021-06-15
2021-06-16
ORBIMED ADVISORS LLC
C - Conversion
Common Stock
2.34M
3
$1.49B
2021-06-15
2021-06-16
RA CAPITAL MANAGEMENT, L.P.
C - Conversion
Series A Convertible Preferred Stock
-4.47M
$0.00
4
$1.49B
2021-06-15
2021-06-16
RA CAPITAL MANAGEMENT, L.P.
C - Conversion
Common Stock
5.73M
4
$1.49B
2021-06-10
2021-06-14
LICHTER JAY
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$1.49B
2021-06-10
2021-06-14
SIMSON JAKE
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$1.49B
2021-06-10
2021-06-14
THOMPSON PETER
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$1.49B